QuanBio operates an integrated physiologic infrastructure spanning continuous hemodynamic monitoring, longitudinal cardiovascular analysis, and outcome-linked evidence generation across clinical and research environments.
Through QuanCardio, the platform enables continuous physiologic monitoring and cardiovascular assessment across cardiac ICUs, recovery programs, and research environments.
Through QuanDigito, the platform generates longitudinal cardiovascular evidence for therapeutic research, recovery analysis, and pharmaceutical applications.
Physiologic Signal Capture
Continuous acquisition of high-fidelity vascular and physiologic signals across clinical environments.
Hemodynamic Interpretation
Biologically grounded AI and cardiovascular computation transforming complex physiologic signals into continuous hemodynamic understanding.
Real-Time Cardiovascular Assessment
Continuous physiologic interpretation supporting cardiovascular assessment, recovery monitoring, and evolving clinical understanding.
Longitudinal Evidence Infrastructure
Continuous cardiovascular data and outcome-linked physiologic analysis supporting translational research and real-world evidence generation.
QuanBio’s platform combines continuous physiologic signal capture with hemodynamic interpretation and biologically grounded AI to characterize cardiovascular function, vascular dynamics, arterial stiffness, and longitudinal physiologic change across clinical and research environments.
Physiologic Biomarkers
Continuous cardiovascular indicators derived from vascular waveform analysis and longitudinal physiologic interpretation.
Arterial Mechanics & Pulse Dynamics
Computational interpretation of vascular waveform morphology supporting cardiovascular assessment, research, and longitudinal physiologic analysis.
A proprietary, non-invasive optical sensor directly captures the raw arterial waveform at the source. By converting high-fidelity photonic interaction into deep vascular physics, QuanBio extracts real-time microvascular structural integrity, systemic perfusion changes, and over 40 proprietary biomarkers. This exclusive data engine powers high-resolution hemodynamic analysis, waveform interpretation, and continuous cardiovascular computation at scale.
